BMJ Best Practice

参考文献

关键文献

Chuh A, Lee A, Zawar V, et al. Pityriasis rosea - an update. Indian J Dermatol Venereol Leprol. 2005;71:311-315.

Chuh A, Zawar V, Lee A. Atypical presentations of pityriasis rosea: case presentations. J Eur Acad Dermatol Venereol. 2005;19:120-126.

Chuh AA, Dofitas BL, Comisel GG, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007;(2):CD005068.

参考文章

1.  Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: how correct is the "classic" description? Arch Pediatr Adolesc Med. 2007;161:503-506.

2.  Dyer JA. Childhood viral exanthems. Pediatr Ann. 2007;36:21-29.

3.  Trager JD. What's your diagnosis? Scaly pubic plaques in a 2-year-old girl - or in an "inverse" rash. J Pediatr Adolesc Gynecol. 2007;20:109-111.

4.  Chuh A, Lee A, Zawar V, et al. Pityriasis rosea - an update. Indian J Dermatol Venereol Leprol. 2005;71:311-315.

5.  Miranda SB, Lupi O, Lucas E. Vesicular pityriasis rosea: response to erythromycin treatment. J Eur Acad Dermatol Venereol. 2004;18:622-625.

6.  Chuh A, Zawar V, Lee A. Atypical presentations of pityriasis rosea: case presentations. J Eur Acad Dermatol Venereol. 2005;19:120-126.

7.  Gonzalez LM, Allen R, Janniger CK, et al. Pityriasis rosea: an important papulosquamous disorder. Int J Dermatol. 2005;44:757-764.

8.  Deng Y, Li H, Chen X. Palmoplantar pityriasis rosea: two case reports. J Eur Acad Dermatol Venereol. 2007;21:406-407.

9.  Chuh A, Chan H, Zawar V. Pityriasis rosea - evidence for and against an infectious aetiology. Epidemiol Infect. 2004;132:381-390.

10.  Bukhari I. Pityriasis rosea with palmoplantar plaque lesions. Dermatol Online J. 2005;11:27.

11.  Stulberg DL, Wolfrey J. Pityriasis rosea. Am Fam Physician. 2004;69:87-91.

12.  Yildirim M, Aridogan BC, Baysal V, et al. The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea. Int J Clin Pract. 2004;58:119-121.

13.  Amer A, Fischer H. Azithromycin does not cure pityriasis rosea. Pediatrics. 2006;117:1702-1705.

14.  Chuh AA, Molinari N, Sciallis G, et al. Temporal case clustering in pityriasis rosea: a regression analysis on 1379 patients in Minnesota, Kuwait, and Diyarbakir, Turkey. Arch Dermatol. 2005;141:767-771.

15.  Cooper M. Diseases of the epidermis: pityriasis rosea, lichen planus, keratosis pilaris. Dermatol Nurs. 2005;17:457-458.

16.  Chuh A, Lee A, Chan PK. Pityriasis rosea in pregnancy - specific diagnostic implications and management considerations. Aust N Z J Obstet Gynaecol. 2005;45:252-253.

17.  Brazzelli V, Prestinari F, Roveda E, et al. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases. J Am Acad Dermatol. 2005;53(suppl 1):S240-S243.

18.  Atzori L, Pinna AL, Ferreli C, et al. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Dermatol Online J. 2006;12:1.

19.  Scheinfeld N. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate. J Drugs Dermatol. 2006;5:228-231.

20.  Chuh AA, Dofitas BL, Comisel GG, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007;(2):CD005068.

21.  Drago F, Rebora A. Treatments for pityriasis rosea. Skin Therapy Lett. 2009;14:6-7.

22.  Tay YK, Goh CL. One-year review of pityriasis rosea at the National Skin Centre, Singapore. Ann Acad Med Singapore. 1999;28:829-831.

23.  Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54:82-85.

24.  American Academy of Dermatologists. Pityriasis rosea. 2017. http://www.aad.org/ (last accessed 19 June 2017).

使用此内容应接受我们的免责声明